Afterwards, the Chinese Medical Association has proposed a comprehensive and dynamic assessment for chronic HBV infection [10], including serum HBV DNA and ALT levels, liver function and disease severity, age, family history of HCC, and concomitant diseases, to guide clinical decisions and therapeutic strategies [4, 106]. This evidence concerns the gene GPT and hepatocellular carcinoma.